Tradestie Institutional Equity Comparison Engine

BMRA vs CODX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BMRA Overall Edge

BMRA Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biomerica Inc (BMRA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CODX counters with relative strength in Valuation. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus CODX at 15.4x Forward P/E and -3415.8% operating margin (+94.6% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CODX sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CODX
BMRA N/M vs CODX 15.4x Fwd P/E
Growth & Margin Winner BMRA
Op Margin -125.2% vs -3415.8% ยท YoY -8.3% vs +94.6%
Momentum & Technical Winner BMRA
1Y -45.6% vs -45.5% ยท 52W Pos 5% vs 0%
Options & Structure Winner BMRA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (50th %ile IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
CODX NASDAQ
Co-Diagnostics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.23
-11.68% 1D
Market Cap $2.3M
1M Return -65.08%
1Y Return -45.54%
Forward P/E 15.4x
Unified AI Score
51.6 / 100 HOLD
Tech 55.0 Fund 54.0 Flow 66.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% CODX -45.54% Spread: +7.0 pp (CODX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue CODX Revenue BMRA Op. Margin CODX Op. Margin Margin Edge
FY2019 $10M $0M -46.4% -2741.6% BMRA
FY2020 $10M $70M -41.0% 55.9% CODX
FY2021 $10M $100M -104.2% 47.1% CODX
FY2022 $20M $30M -24.0% -78.8% BMRA
FY2023 $10M $10M -135.3% -626.9% BMRA
FY2024 $10M $0M -117.6% -1023.7% BMRA
FY2025 $10M $0M -96.7% -8058.8% BMRA
FY2026 $0M N/A -119.5% N/A BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (4) vs CODX (5)
Institutional Metric BMRA CODX Criterion Row Winner
Market Capitalization Scale $6.0M $2.3M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 15.4x Lower Multiple CODX
Forward P/E Ratio Valuation N/M 15.4x Lower Multiple CODX
Revenue Growth (YoY) Growth -8.3% +94.6% Higher Growth CODX
Operating Margin (TTM) Profitability -125.2% -3415.8% Higher Margin BMRA
Net Profit Margin Profitability -115.5% 0.0% Higher Margin CODX
Return on Equity (ROE) Capital Efficiency -113.8% -192.8% Higher ROE BMRA
52-Week Range Position Momentum 5% ($1โ€“$3) 0% ($0โ€“$14) Stronger Trend BMRA
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 2.93ฮฒ ยท 148% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite CODX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs CODX Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CODX BREAKDOWN
173d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CODX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor CODX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.